Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage / R. Lombardi, S. Petta, G. Pisano, P. Dongiovanni, L. Rinaldi, L.E. Adinolfi, C. Acierno, L. Valenti, R. Boemi, F. Spatola, A. Craxi, S. Fargion, A.L. Fracanzani. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - 18:2(2020 Feb), pp. 517-519. [10.1016/j.cgh.2018.11.011]
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage
R. Lombardi;G. Pisano;P. Dongiovanni;L. Valenti;S. Fargion;A.L. Fracanzani
2020
Abstract
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1542356518312540-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
139.61 kB
Formato
Adobe PDF
|
139.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.